5-(2-chlorophenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 5g

Maprotiline Hydrochloride, >98.0%(HPLC)(T), 5g

4-Amino-3-methoxy-N-methylbenzamide, 97%, 1g

Alcool benzylique, min 98 %, pour la synthèse, 500 ml, emballage en verre

Dimethyl hexafluoroglutarate, 98.0%, 1g

(3-Fluoro-4-morpholinophenyl)boronic acid, 95.0%, 1g

3-Bromo-N-ethylaniline, 95+%, 1g

Imidazo[1,2-a]pyridine-3-carboxylic acid, 6-[5-[(phenylsulfonyl)amino]-3-pyridinyl]-, ethyl ester, 97%, 25mg

5-Methyl-1-benzofuran-3-carboxylic acid, 95%, 50mg

Zinc sulfate heptahydrate, 99.0%, 1kg

2-IODO-5-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 250mg

1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95.0%, 250mg

2-Hydroxy-6-methylisonicotinic acid, 97.0%, 1g